CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated earnings less dividends	Accumulated other comprehensive income (loss)
Beginning Balance at Dec. 31, 2022	$ 11,253,553	$ 1,400	$ 10,765,508	$ 485,221	$ 1,424
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to common stockholders	146,902			146,902
Gain on cash flow hedges, net	(340)				(340)
Cash flow hedge losses reclassified to earnings	354				354
Noncontrolling interest activity	(286)			(286)
Dividends declared to common stockholders	(230,958)			(230,958)
Issuance of common stock, net of withholdings	(9,963)	1	(11,554)	1,590
Repurchase of common stock, including repurchase costs	(1,129)		(539)	(590)
Amortization of deferred compensation	11,123		11,123
Ending Balance at Mar. 31, 2023	11,169,256	1,401	10,764,538	401,879	1,438
Beginning Balance at Dec. 31, 2023	11,783,318	1,420	11,287,626	478,156	16,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to common stockholders	173,449			173,449
Gain on cash flow hedges, net	7,339				7,339
Cash flow hedge losses reclassified to earnings	146				146
Dividends declared to common stockholders	(242,701)			(242,701)
Issuance of common stock, net of withholdings	(15,757)	2	(16,226)	467
Amortization of deferred compensation	8,440		8,440
Ending Balance at Mar. 31, 2024	$ 11,714,234	$ 1,422	$ 11,279,840	$ 409,371	$ 23,601